Clinical Trial Site
Nanchang 330009
2 studies enrolling now · 2 studies all time
What they study most
Generalized Myasthenia Gravis, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension
Studies at this site
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
- Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs) — Recruiting now